InvestingGeNeuro Announces Last Patient Last Visit in its Post-COVID Trial and Confirms Top-Line Results by End of June 2024 by TheCompaniesMay 16, 20240 Share0 Facebook Twitter Google+ Pinterest Amazon reddit LinkedIn Myspace